Company profile: Eucodis Bioscience
1.1 - Company Overview
Company description
- Provider of high-performance enzyme solutions, offering enzyme engineering for industrial customers across the chemical, pharmaceutical, cosmetics, and food and feed industries.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Eucodis Bioscience
Gelpell
HQ: Switzerland
Website
- Description: Provider of manufacturing for food supplements and nutrients, offering soft gelatin capsules for oily and semi-solid preparations; Gelpell® beads for slow, even release and improved bioavailability; hard capsules with powders or Gelpell® beads; plant-based pea-starch soft capsules; blister packaging compliant with pharmaceutical standards; and bulk product supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gelpell company profile →
Bioscript
HQ: United Kingdom
Website
- Description: Provider of regulatory consulting, product lifecycle support, and strategic medical communications services. Offerings include medical communications, market access consulting, regulatory writing, Bioscript Data Insights with tools like KOLNavigator, PubsNavigator and EventsNavigator, plus rare disease and oncology consulting covering strategy, engagement, communications, market access and regulatory writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioscript company profile →
Q1 Scientific
HQ: Ireland
Website
- Description: Provider of environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q1 Scientific company profile →
TMC Pharma Services
HQ: United Kingdom
Website
- Description: Provider of pharmaceutical and biotech drug development support, offering clinical and nonclinical services, medical support and pharmacovigilance. Capabilities include regulatory strategy and submissions (pre- and post-approval), GxP quality assurance audits and consultancy, medical writing, orphan drug designation applications, paediatric investigation plans, and clinical trial applications with pre-clinical data review/validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TMC Pharma Services company profile →
AbbVie
HQ: United States
Website
- Description: Provider of contract development and manufacturing services for pharmaceutical companies across small and large molecules and biologics. Offerings include aseptic fill-finish of parenteral vials and prefilled syringes; biologics and antibody-drug conjugate manufacturing; API process optimization, tech transfer, and analytical development; turnkey ophthalmic filling and packaging; hot melt extrusion to improve API solubility and bioavailability; and microbial fermentation for API process development and commercial manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AbbVie company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Eucodis Bioscience
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Eucodis Bioscience
2.2 - Growth funds investing in similar companies to Eucodis Bioscience
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Eucodis Bioscience
4.2 - Public trading comparable groups for Eucodis Bioscience
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →